← Back to Clinical Trials
Recruiting NCT04489199

NCT04489199 Dijon Stroke Cohort

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04489199
Status Recruiting
Phase
Sponsor Centre Hospitalier Universitaire Dijon
Condition CVA, Dijon Registry
Study Type OBSERVATIONAL
Enrollment 4,000 participants
Start Date 2021-01-01
Primary Completion 2040-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Questionnaire and semi-structured interview

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 4,000 participants in total. It began in 2021-01-01 with a primary completion date of 2040-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Dijon Stroke Registry, accredited by the Registry Evaluation Committee, INSERM and Public Health France, has been studying the epidemiology of cerebrovascular accidents (cerebral infarction, intracerebral haemorrhages, meningeal haemorrhages) and transient ischaemic attacks (TIAs) within the city of Dijon since 1985. As a result of the development of therapies for acute disease, the prognosis of patients has improved over time. Thus, the number of stroke survivors has increased by 90% between the 1980s and today. This raises new issues: risk of vascular recurrence, drug iatrogeny, and functional impact of stroke for motor, cognitive or thymic function. In the absence of available data in France, the investigators wish to set up an extended cohort follow-up of patients in order to study their long-term prognosis and to study the impact of future therapies on the evolutionary course of the disease.

Eligibility Criteria

Inclusion Criteria: * patients included in the Dijon Stroke Registry and not opposed to participating Exclusion Criteria: * minor patients; opposition to participation

Contact & Investigator

Central Contact

Yannick BEJOT

✉ yannick.bejo@chu-dijon.fr

📞 03.80.29.37.53

Frequently Asked Questions

Who can join the NCT04489199 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying CVA, Dijon Registry. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04489199 currently recruiting?

Yes, NCT04489199 is actively recruiting participants. Contact the research team at yannick.bejo@chu-dijon.fr for enrollment information.

Where is the NCT04489199 trial being conducted?

This trial is being conducted at Dijon, France.

Who is sponsoring the NCT04489199 clinical trial?

NCT04489199 is sponsored by Centre Hospitalier Universitaire Dijon. The trial plans to enroll 4,000 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology